Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Linezolid (as component of XDR-TB regimen)
Treatment for HIV/AIDS - Extensively drug-resistant Tuberculosis
Typical Dosage: 600mg daily (often reduced to 300mg daily)
Effectiveness
80%
Safety Score
34%
Clinical Trials
50
Participants
10K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
34
DangerousModerateSafe
Treatment Details
Dosage Range
600mg daily (often reduced to 300mg daily)
Time to Effect
Contributes to sputum conversion within weeks (as part of regimen)
Treatment Duration
Typically 6-9 months (as part of regimen)
Evidence Quality
HIGHNumber Needed to Harm (NNH)
7(Treat 7 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$3,000
Monitoring:$2,000
Side Effect Mgmt:$3,000
Total Annual:$8,000
Linezolid (as component of XDR-TB regimen) Outcomes
for HIV/AIDS - Extensively drug-resistant Tuberculosis
Efficacy Outcomes
Overall Effectiveness
+80%
Common Side Effects
Peripheral neuropathy
+60%
Myelosuppression (anemia, thrombocytopenia)
+25%
Optic neuropathy
+7%
Lactic acidosis
+5%
Gastrointestinal disturbances
+15%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov